(Q42469138)

1 November 2017

title

Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero (English)

1 reference

1 November 2017

1 reference

Bilbao R

1

1 reference

1 November 2017

Reay DP

2

1 reference

1 November 2017

Wu E

3

1 reference

1 November 2017

Zheng H

4

1 reference

1 November 2017

Biermann V

5

1 reference

1 November 2017

Kochanek S

6

1 reference

1 November 2017

Clemens PR

7

1 reference

1 November 2017

publication date

1 January 2005

1 reference

1 November 2017

1 reference

1 November 2017

volume

12

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

39-47

1 reference

Immune response to full-length dystrophin delivered to Dmd muscle by a high-capacity adenoviral vector

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Intrauterine gene transfer: gestational stage-specific gene delivery in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Humoral immune response to recombinant adenovirus and adeno-associated virus after in utero administration of viral vectors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Temporally regulated expression patterns following in utero adenovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Sustained delivery of therapeutic concentrations of human clotting factor IX--a comparison of adenoviral and AAV vectors administered in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Persistent postnatal transgene expression in both muscle and liver after fetal injection of recombinant adenovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

High-capacity adenoviral vectors for gene transfer and somatic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Germline incorporation of a replication-defective adenoviral vector in mice does not alter immune responses to adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

The spread of transgene expression at the site of gene construct injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Targeting of high-capacity adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Binding of adenoviral fiber knob to the coxsackievirus-adenovirus receptor is crucial for transduction of fetal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Polylysine modification of adenoviral fiber protein enhances muscle cell transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

A simple method for the rapid generation of recombinant adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

A new blocking method for application of murine monoclonal antibody to mouse tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302392

21 January 2018

Identifiers

DOI

10.1038/SJ.GT.3302392

1 reference

Dimensions Publication ID

1 November 2017

1031134815

0 references

1 reference